Harte Hanks vs WidePoint
HHS and WYY side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HHS and WYY compare
WidePoint is the larger company, worth 2.0 times as much as Harte Hanks ($56.0M against $28.0M).
WidePoint grew revenue faster over the last twelve months (9.7% versus −11.6% for Harte Hanks).
WidePoint keeps more of each dollar of sales as profit, with a net margin of −0.81% compared with −3.7% at Harte Hanks.
WidePoint scores higher on the StockData Score (8 against 5 for Harte Hanks), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HHS | WYY |
|---|---|---|
| Size and price | ||
| Market cap | $28.0M | $56.0M |
| Share price | $3.76 | $5.60 |
| Change, 1 year | 26.2% | −9.7% |
| Change, 5 years | −53.0% | 23.1% |
| Beta (5Y) | 2.39 | 1.14 |
| Employees | 1,719 | 243 |
| StockData Score | ||
| Total score | 5 | 8 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 2 (better) |
| Health score | 4 | 4 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.2× (better) | 0.4× |
| P/B | 1.8× (better) | 4.8× |
| P/FCF | – | 12.4× |
| FCF yield | −5.2% | 8.1% (better) |
| Fair value | – | $2.46 |
| Margin of safety | – | −128% |
| Growth | ||
| Revenue growth (TTM) | −11.6% | 9.7% (better) |
| Revenue growth, 5Y average | −2.0% | 48.8% (better) |
| Profitability | ||
| Gross margin | – | 14.4% |
| Operating margin | −3.1% | −0.83% (better) |
| Net margin | −3.7% | −0.81% (better) |
| FCF margin | −0.94% | 2.9% (better) |
| Return on equity | −30.4% | −10.4% (better) |
| Return on invested capital | −25.0% (better) | −29.5% |
| Financial health | ||
| Debt / equity | 0.20 (better) | 0.00 |
| Interest coverage | – | −7.1× |
| Current ratio | 1.30 (better) | 1.04 |
| Altman Z-score | 14.80 (better) | 0.75 |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 29.1% | 26.3% |
| Held by insiders | 39.8% | 12.0% |
| Insider net buying, 12 months | – | −$7.2M |
| Short interest, % of float | 0.98% | 2.1% |
Go deeper
- HHS stock overview
- HHS income statement
- HHS valuation and score
- WYY stock overview
- WYY income statement
- WYY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.